Ved postmenopausal hormonbehandling bør den terapeutiske virkning monitoreres når der samtidig behandles med VIRAMUNE.
Additionally, when postmenopausal hormone therapy is used during administration of VIRAMUNE, its therapeutic effect should be monitored.